Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

A series of analgesic agents prepared and tested by Boehringer Ingelheim

Dec. 15, 2004

New dopamine D3 receptor ligands in early development at Abbott

Dec. 15, 2004

Antibacterial pleuromutilin derivatives claimed by GlaxoSmithKline

Dec. 15, 2004

New adenosine receptor antagonists and their use described in Fujisawa patent

Dec. 14, 2004

New treatments for Parkinson's disease claimed in Schering patent

Dec. 14, 2004

Roche patent covers novel adenosine receptor modulators for Alzheimer's, Parkinson's, etc.

Dec. 14, 2004

Wyeth researchers develop an antibiotic from Micromonospora

Dec. 14, 2004

Boehringer Ingelheim scientists report agents for the treatment of hepatitis C infection

Dec. 14, 2004

New prostaglandin I2 receptor antagonists in early development at Roche

Dec. 14, 2004

Roche claims CRF receptor antagonists and their use in stress-related disorders, anxiety, etc.

Dec. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...